Common Contracts
24 similar At Market Issuance Sales Agreement contracts by Cherry Hill Mortgage Investment Corp, MONROE CAPITAL Corp, Stellus Capital Investment Corp, others
CHERRY HILL MORTGAGE INVESTMENT CORPORATIONAt Market Issuance Sales Agreement • August 9th, 2024 • Cherry Hill Mortgage Investment Corp • Real estate investment trusts • New York
Cherry Hill Mortgage Investment Corporation, a Maryland corporation (the “Company”), confirms its agreement (this “Agreement”), with BTIG, LLC (the “Agent”), as follows:
SONIM TECHNOLOGIES, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • September 24th, 2021 • Sonim Technologies Inc • Telephone & telegraph apparatus • New York
Sonim Technologies, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with B. Riley Securities, Inc. (the “Agent”) as follows:
At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • January 27th, 2021 • Aemetis, Inc • Industrial organic chemicals • New York
Aemetis, Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (“Distribution Agent” and “HCW”) as follows:
SEQUANS COMMUNICATIONS S.A. American Depositary Shares each representing four fully paid Ordinary Shares, Nominal Value €0.02 Per Share At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • March 31st, 2020 • Sequans Communications • Semiconductors & related devices • New York
GLOBAL SHIP LEASE, INC. At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • November 27th, 2019 • Global Ship Lease, Inc. • Deep sea foreign transportation of freight • New York
ContractAt Market Issuance Sales Agreement • September 23rd, 2019 • B. Riley Financial, Inc. • Services-business services, nec • New York
At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • September 9th, 2019 • Stellus Capital Investment Corp • New York
SACHEM CAPITAL CORP. Common Stock ($0.001 par value per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • November 9th, 2018 • Sachem Capital Corp. • Real estate investment trusts • New York
Sachem Capital Corp., a New York corporation (the “Company”), confirms its agreement (this “Agreement”), with B. Riley FBR, Inc. (the “Agent”), as follows:
SACHEM CAPITAL CORP. Common Stock ($0.001 par value per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • October 19th, 2018 • Sachem Capital Corp. • Real estate investment trusts • New York
Sachem Capital Corp., a New York corporation (the “Company”), confirms its agreement (this “Agreement”), with B. Riley FBR, Inc. (the “Agent”), as follows:
CHERRY HILL MORTGAGE INVESTMENT CORPORATIONAt Market Issuance Sales Agreement • August 31st, 2018 • Cherry Hill Mortgage Investment Corp • Real estate investment trusts • New York
Cherry Hill Mortgage Investment Corporation, a Maryland corporation (the “Company”), confirms its agreement (this “Agreement”), with JMP Securities LLC (the “Agent”), as follows:
CHERRY HILL MORTGAGE INVESTMENT CORPORATIONAt Market Issuance Sales Agreement • August 31st, 2018 • Cherry Hill Mortgage Investment Corp • Real estate investment trusts • New York
Cherry Hill Mortgage Investment Corporation, a Maryland corporation (the “Company”), confirms its agreement (this “Agreement”), with B. Riley FBR, Inc. (the “Agent”), as follows:
CHERRY HILL MORTGAGE INVESTMENT CORPORATION At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • April 5th, 2018 • Cherry Hill Mortgage Investment Corp • Real estate investment trusts • New York
Cherry Hill Mortgage Investment Corporation, a Maryland corporation (the “Company”), confirms its agreement (this “Agreement”), with B. Riley FBR, Inc. (the “Agent”), as follows:
CHERRY HILL MORTGAGE INVESTMENT CORPORATION At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • April 5th, 2018 • Cherry Hill Mortgage Investment Corp • Real estate investment trusts • New York
Cherry Hill Mortgage Investment Corporation, a Maryland corporation (the “Company”), confirms its agreement (this “Agreement”), with JMP Securities LLC (the “Agent”), as follows:
At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • August 23rd, 2017 • Stellus Capital Investment Corp • New York
At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • June 9th, 2017 • Southern Missouri Bancorp, Inc. • Savings institutions, not federally chartered • New York
Southern Missouri Bancorp, Inc., a Missouri corporation (the "Company"), confirms its agreement (this "Agreement"), with Keefe, Bruyette & Woods, Inc. ("KBW") or (the "Distribution Agent") as follows:
Amended and Restated At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • May 12th, 2017 • MONROE CAPITAL Corp • New York
Amended and Restated At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • May 12th, 2017 • MONROE CAPITAL Corp • New York
At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • February 6th, 2015 • MONROE CAPITAL Corp • New York
Each of Monroe Capital Corporation, a Maryland corporation (the “Company”), Monroe Capital BDC Advisors, LLC, a Delaware limited liability company (the “Adviser”), registered as an investment advisor under the Investment Advisers Act of 1940, as amended, and the rules and regulations thereunder (the “Advisers Act”), and Monroe Capital Management Advisors, LLC, a Delaware limited liability company (the “Administrator”) confirms its agreement (this “Agreement”) with JMP Securities LLC (the “Agent”), as follows:
At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • February 6th, 2015 • MONROE CAPITAL Corp • New York
Each of Monroe Capital Corporation, a Maryland corporation (the “Company”), Monroe Capital BDC Advisors, LLC, a Delaware limited liability company (the “Adviser”), registered as an investment advisor under the Investment Advisers Act of 1940, as amended, and the rules and regulations thereunder (the “Advisers Act”), and Monroe Capital Management Advisors, LLC, a Delaware limited liability company (the “Administrator”) confirms its agreement (this “Agreement”) with MLV & Co. LLC (the “Agent”), as follows:
AGENUS INC. Common Stock (par value 0.01) AT MARKET ISSUANCE SALES AGREEMENTAt Market Issuance Sales Agreement • October 10th, 2014 • Agenus Inc • Biological products, (no disgnostic substances) • New York
Agenus Inc., a Delaware corporation (the “Company”), confirms its agreement with MLV & Co. LLC, a Delaware limited liability company (“MLV” or the “Agent”), as follows:
At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • June 5th, 2014 • Stellus Capital Investment Corp • New York
Each of Stellus Capital Investment Corporation, a Maryland corporation (the “Company”), and Stellus Capital Management, LLC, a Delaware limited liability company (the “Adviser”), registered as an investment advisor under the Investment Advisers Act of 1940, as amended, and the rules and regulations thereunder (the “Advisers Act”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (the “Agent”), as follows:
At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • June 5th, 2014 • Stellus Capital Investment Corp • New York
Each of Stellus Capital Investment Corporation, a Maryland corporation (the “Company”), and Stellus Capital Management, LLC, a Delaware limited liability company (the “Adviser”), registered as an investment adviser under the Investment Advisers Act of 1940, as amended, and the rules and regulations thereunder (the “Advisers Act”), confirms its agreement (this “Agreement”) with Raymond James & Associates, Inc. (the “Agent”), as follows:
AGENUS INC. Common Stock (par value 0.01) AMENDED AND RESTATED AT MARKET ISSUANCE SALES AGREEMENTAt Market Issuance Sales Agreement • December 21st, 2012 • Agenus Inc • Biological products, (no disgnostic substances) • New York
Agenus Inc., a Delaware corporation (the “Company”), and MLV & Co. LLC, a Delaware limited liability company (“MLV” or the “Agent”), are parties to that certain At Market Issuance Sales Agreement dated March 2, 2012 (the “Original Sales Agreement”). The Company and MLV desire to amend and restate the Original Sales Agreement with this agreement (the “Agreement”), and hereby agree as follows:
AGENUS INC. Common Stock (par value 0.01) AT MARKET ISSUANCE SALES AGREEMENTAt Market Issuance Sales Agreement • March 2nd, 2012 • Agenus Inc • Biological products, (no disgnostic substances) • New York
Agenus Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC, a Delaware limited liability company (“MLV” or the “Agent”), as follows: